RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,112,000 | -38.2% | 914,235 | -25.3% | 0.42% | -48.2% |
| Q1 2021 | $3,416,000 | +41.0% | 1,224,264 | +44.0% | 0.81% | +25.0% |
| Q4 2020 | $2,423,000 | +62.3% | 850,129 | +19.6% | 0.65% | +3.5% |
| Q3 2020 | $1,493,000 | -67.3% | 711,043 | -29.2% | 0.63% | -73.1% |
| Q2 2020 | $4,570,000 | +44.0% | 1,004,466 | +158.6% | 2.33% | -16.7% |
| Q1 2020 | $3,173,000 | – | 388,417 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |